Treatments for child and adolescent attention deficit hyperactivity disorder in low and middle-income countries: A narrative review

Aguiar, 2014, Increasing teachers’ knowledge about ADHD and learning disorders: an investigation on the role of a psychoeducational intervention, J. Atten. Disord., 18, 691, 10.1177/1087054712453171 Ali, 2016, Validated screening tools for common mental disorders in low and middle income countries: a systematic review, PLoS. One, 11, 10.1371/journal.pone.0156939 Altin, 2013, Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries, Drugs Context., 10.7573/dic.212260 Association, 2013 Atkinson, 2010, NICE guideline: attention deficit hyperactivity disorder, Arch. Dis. Child. Educ. Pract. Ed., 95, 24, 10.1136/adc.2009.175943 Bachmann, 2017, Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012, Eur. Neuropsychopharmacol., 27, 484, 10.1016/j.euroneuro.2017.03.002 Barkley, 2010 Barned, 2011, Knowledge and attitudes of early childhood preservice teachers regarding the inclusion of children with autism spectrum disorder, J. Early Child. Teach. Educ., 32, 302, 10.1080/10901027.2011.622235 Barner, 2011, ADHD medication use, adherence, persistence and cost among Texas Medicaid children, Curr. Med. Res. Opin., 27, 13, 10.1185/03007995.2011.603303 Barry, 2013, A systematic review of the effectiveness of mental health promotion interventions for young people in low and middle income countries, BMC Public. Health, 13, 835, 10.1186/1471-2458-13-835 BenAmor, 2014, 1H-Magnetic resonance spectroscopy study of stimulant medication effect on brain metabolites in French Canadian children with attention deficit hyperactivity disorder, Neuropsychiatr. Dis. Treat., 10, 47, 10.2147/NDT.S52338 Biederman, 2004, Impact of comorbidity in adults with attention deficit/hyperactivity disorder, J. Clin. Psychiatry Caqueo-Urizar, 2020, Psychiatric disorders in children and adolescents in a middle-income Latin American country, BMC Psychiatry, 20, 10.1186/s12888-020-02512-4 Caye, 2019, Treatment strategies for ADHD: an evidence-based guide to select optimal treatment, Mol. Psychiatry, 24, 390, 10.1038/s41380-018-0116-3 Charach, 2004, Stimulant treatment over five years: adherence, effectiveness, and adverse effects, J. Am. Acad. Child. Adolesc. Psychiatry, 43, 559, 10.1097/00004583-200405000-00009 Chazan, 2011, J. Clin. Psychopharmacol., 31, 309, 10.1097/JCP.0b013e318217b4df Cherkasova, 2020, Efficacy of cognitive behavioral therapy with and without medication for adults with ADHD: a randomized clinical trial, J. Atten. Disord., 24, 889, 10.1177/1087054716671197 Cheung, 2016, Cognitive and neurophysiological markers of ADHD persistence and remission, Br. J. Psychiatry, 208, 548, 10.1192/bjp.bp.114.145185 Cork, 2019, The integration of idioms of distress into mental health assessments and interventions: a systematic review, Glob. Ment. Health, 6 Danforth, 2006, Parent training for families of children with comorbid ADHD and ODD, Int. J. Behav. Consult. Ther., 2, 45, 10.1037/h0100766 Dvorsky, 2019, Predicting impairment in college students with ADHD: the role of executive functions, J. Atten. Disord., 23, 1624, 10.1177/1087054714548037 Faraone, 2003, The worldwide prevalence of ADHD: is it an American condition?, World Psychiatry, 2, 104 Fazel, 2014, Mental health interventions in schools in low-income and middle-income countries, Lancet Psychiatry, 1, 388, 10.1016/S2215-0366(14)70357-8 Fleitlich-Bilyk, 2004, Prevalence of child and adolescent psychiatric disorders in southeast Brazil, J. Am. Acad. Child. Adolesc. Psychiatry, 43, 727, 10.1097/01.chi.0000120021.14101.ca Flisher, 2010, Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countries, PLoS Med., 7, 1, 10.1371/journal.pmed.1000235 Forehand, 2016, Which type of parent training works best for preschoolers with comorbid ADHD and ODD? A secondary analysis of a randomized controlled trial comparing generic and specialized programs, J. Abnorm. Child. Psychol., 44, 1503, 10.1007/s10802-016-0138-8 Froehlich, 2007, Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children, Arch. Pediatr. Adolesc. Med., 161, 857, 10.1001/archpedi.161.9.857 Fullen, 2020, Psychological treatments in adult ADHD: a systematic review, J. Psychopathol. Behav. Assess., 1 Garg, 2014, Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder, Indian. Pediatr., 51, 550, 10.1007/s13312-014-0445-5 Gau, 2008, National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan, J. Clin. Psychiatry, 69, 131, 10.4088/JCP.v69n0118 Gul, 2021, Role of the norepinephrine transporter polymorphisms in atomoxetine treatment: from response to side effects in children with ADHD, J. Psychopharmacol. Hamza, 2018, the cognitive remediation therapy Program among children with aDHD: Tunisian experience la remédiation cognitive dans le trouble Déficit de l′attention Hyperactivité: expérience tunisienne, Tunis. Med., 96 Harrison, 2011, Behaviors that discriminate ADHD in children and adolescents: primary symptoms, symptoms of comorbid conditions, or indicators of functional impairment?, J. Atten. Disord., 15, 147, 10.1177/1087054709356170 Hartog, 2020, Stigma reduction interventions for children and adolescents in low-and middle-income countries: systematic review of intervention strategies, Soc. Sci. Med., 246, 10.1016/j.socscimed.2019.112749 Healy, 2018, Family-based youth mental health interventions delivered by nonspecialist providers in low-and middle-income countries: a systematic review, Fam. Syst. Health, 36, 182, 10.1037/fsh0000334 Heim, 2020, Reducing mental health-related stigma in primary health care settings in low-and middle-income countries: a systematic review, Epidemiol. Psychiatr. Sci., 29 Honorio Neto, 2021, A mixed methods study of clinician reported challenges in the assessment of ADHD and treatment decisions for children with ADHD in Brazil, Clin. Child. Psychol. Psychiatry, 26, 505, 10.1177/1359104521994634 Howard, 2016, Progression of impairment in adolescents with ADHD through the transition out of high school: contributions of parent involvement and college attendance, J. Abnorm. Psychol., 125, 233, 10.1037/abn0000100 Jayamaha, 2018, A cross sectional survey of adherence, perceived efficacy and side effects of methylphenidate among children at a teaching hospital in Sri Lanka, Sri Lanka. J. Psychiatry, 9, 69, 10.4038/sljpsyc.v9i2.8186 Kariuki, 2018, Evaluation of psychometric properties and factorial structure of ADHD module of K-SADS-PL in children from rural Kenya, J. Atten. Disord. Kariyawasam, 2005, Methylphenidate in children with attention-deficit hyperactivity disorder (ADHD): experience from a Sri Lankan Tertiary Children's Hospital, J. Child. Neurol., 20, 496, 10.1177/08830738050200060501 Kessler, 2006, The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication, Am. J. Psychiatry, 163, 716, 10.1176/ajp.2006.163.4.716 Klasen, 2013, What works where? A systematic review of child and adolescent mental health interventions for low and middle income countries, Soc. Psychiatry Psychiatr. Epidemiol., 48, 595, 10.1007/s00127-012-0566-x Koneski, 2011, Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review, Epilepsy Behav., 21, 228, 10.1016/j.yebeh.2011.02.029 Kooij, 2019, Updated European Consensus Statement on diagnosis and treatment of adult ADHD, Eur. Psychiatry, 56, 14, 10.1016/j.eurpsy.2018.11.001 Lange, 2018, Parent training for preschool ADHD in routine, specialist care: a randomized controlled trial, J. Am. Acad. Child. Adolesc. Psychiatry, 57, 593, 10.1016/j.jaac.2018.04.014 LeRoy, 2019, Neuropsychological performance patterns of adult ADHD subtypes, J. Atten. Disord., 23, 1136, 10.1177/1087054718773927 Maalouf, 2016, Psychiatric disorders among adolescents from Lebanon: prevalence, correlates, and treatment gap, Soc. Psychiatry Psychiatr. Epidemiol., 51, 1105, 10.1007/s00127-016-1241-4 Maia, 2016, Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil, Braz. J. Psychiatry, 38, 30, 10.1590/1516-4446-2014-1516 Malik, 2017, Preliminary efficacy of a behavioral parent training program for children with ADHD in Pakistan, J. Atten. Disord., 21, 390, 10.1177/1087054714524158 Mascayano, 2015, Addressing stigma relating to mental illness in low-and middle-income countries, Front. Psychiatry, 6, 38, 10.3389/fpsyt.2015.00038 Mattingly, 2017, A clinician’s guide to ADHD treatment options, Postgrad. Med., 129, 657, 10.1080/00325481.2017.1354648 Mehta, 2012, Peer-mediated multimodal intervention program for the treatment of children with ADHD in India: one-year followup, Int. Sch. Res. Not., 2012 Mishra, 2016, Training sensory signal-to-noise resolution in children with ADHD in a global mental health setting, Transl. Psychiatry, 6, 10.1038/tp.2016.45 Montiel, 2008, Prevalence rates of attention deficit/hyperactivity disorder in a school sample of Venezuelan children, Child. Psychiatry Hum. Dev., 39, 311, 10.1007/s10578-007-0090-5 Mrug, 2012, Peer rejection and friendships in children with attention-deficit/hyperactivity disorder: contributions to long-term outcomes, J. Abnorm. Child. Psychol., 40, 1013, 10.1007/s10802-012-9610-2 Nair, 2009, Randomised controlled study-efficacy of clonidine versus carbamazepine in children with ADHD, J. Trop. Pediatr., 55, 116, 10.1093/tropej/fmn117 Patel, 2007, Treatment and prevention of mental disorders in low-income and middle-income countries, Lancet, 370, 991, 10.1016/S0140-6736(07)61240-9 Peasgood, 2016, The impact of ADHD on the health and well-being of ADHD children and their siblings, Eur. Child. Adolesc. Psychiatry, 25, 1217, 10.1007/s00787-016-0841-6 Pendergast, 2014, Factor structure of scores from the Conners' rating scales–revised among Nepali children, Int. J. Sch. Educ. Psychol., 2, 261, 10.1080/21683603.2013.878678 Perera, 2012, Combined ω3 and ω6 supplementation in children with attention-deficit hyperactivity disorder (ADHD) refractory to methylphenidate treatment: a double-blind, placebo-controlled study, J. Child. Neurol., 27, 747, 10.1177/0883073811435243 Rejani, 2012, Efficacy of multimodal intervention for children with attention deficit hyperactivity disorder (ADHD)-an Indian study, J. Behav. Brain Sci., 2, 117, 10.4236/jbbs.2012.21014 Sasser, 2017, Targeting functional impairments in the treatment of children and adolescents with ADHD, CNS Drugs, 31, 97, 10.1007/s40263-016-0400-1 Sayal, 2018, ADHD in children and young people: prevalence, care pathways, and service provision, Lancet Psychiatry, 5, 175, 10.1016/S2215-0366(17)30167-0 Schatz, 2006, ADHD with comorbid anxiety: a review of the current literature, J. Atten. Disord., 10, 141, 10.1177/1087054706286698 Schatz, 2015, Systematic review of patients’ and parents’ preferences for ADHD treatment options and processes of care, Patient, 8, 483, 10.1007/s40271-015-0112-5 Sharan, 2009, Mental health research priorities in low- and middle-income countries of Africa, Asia, Latin America and the Caribbean, Br. J. Psychiatry, 195, 354, 10.1192/bjp.bp.108.050187 Sitholey, 2011, A preliminary study of factors affecting adherence to medication in clinic children with attention-deficit/hyperactivity disorder, Indian. J. Psychiatry, 53, 41, 10.4103/0019-5545.75561 Skodzik, 2017, Long-term memory performance in adult ADHD: a meta-analysis, J. Atten. Disord., 21, 267, 10.1177/1087054713510561 Sobanski, 2014, Treatment adherence and persistence in adult ADHD: results from a twenty-four week controlled clinical trial with extended release methylphenidate, Eur. Psychiatry, 29, 324, 10.1016/j.eurpsy.2013.08.004 Szobot, 2004, The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: a randomized clinical trial, J. Atten. Disord., 8, 37, 10.1177/108705470400800201 Szobot, 2008, A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder, Braz. J. Med. Biol. Res., 41, 250, 10.1590/S0100-879X2008005000011 Treuer, 2014, Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention‐deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates, Int. J. Clin. Pract., 68, 1152, 10.1111/ijcp.12437 Van‘t Hof, 2011, Psychological treatments for depression and anxiety disorders in low-and middle-income countries: a meta-analysis, Afr. J. Psychiatry, 14, 200, 10.4314/ajpsy.v14i3.2 Vrba, 2016, Management of ADHD in children and adolescents: clinical audit in a South African setting, J. Child. Adolesc. Ment. Health, 28, 1, 10.2989/17280583.2015.1128437 Wiguna, 2012, Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS), Clin. Neuropharmacol., 35, 81, 10.1097/WNF.0b013e3182452572